IDO2 and rheumatoid arthritis: Thus, the studies conducted on the involvement of IDO2 in RA defined a key pathogenic role of the enzyme in the development of the pathology [48] and offered a proof of concept for antibody-mediated targeting of IDO2 as a new therapeutic strategy to treat RA.